Auro Laboratories zooms on getting WHO-GMP certificate for Tarapur API facility
Auro Laboratories is currently trading at Rs 195.90, up by 13.05 points or 7.14% from its previous closing of Rs 182.85 on the BSE.
The scrip opened at Rs 195.00 and has touched a high and low of Rs 199.00 and Rs 189.40 respectively. So far 3455 shares were traded on the counter.
The BSE group 'X' stock of face value Rs 10 has touched a 52-week high of Rs 303.00 on 17-Jul-2025 and a 52-week low of Rs 159.00 on 12-Nov-2025.
Last one week high and low of the scrip stood at Rs 200.00 and Rs 159.00 respectively. The current market cap of the company is Rs 118.48 crore.
The promoters holding in the company stood at 52.18%, while Institutions and Non-Institutions held 0.01% and 47.82% respectively.
Auro Laboratories has received World Health Organization-Good Manufacturing Practices (WHO - GMP) certificate from the Food & Drug Administration, Maharashtra, for its Active Pharmaceutical Ingredients (API) (Bulk Drugs) manufacturing located in MIDC Tarapur, Maharashtra. The certificate is valid up to September 30, 2028.
The company has received this certificate after it successfully completed WHO inspection at its API Tarapur manufacturing facility.
Auro Laboratories is a manufacturer of Active Pharmaceutical Ingredients (APIs), Intermediates and Generic Formulations.
.jpg)